Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

BACKGROUND: Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B (AmB) for the treatment of CL. METHODOLOGY/PRINCIPAL FINDINGS: Liposomes conta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Parasitol Drugs Drug Resist
Autors principals: Jaafari, Mahmoud Reza, Hatamipour, Mahdi, Alavizadeh, Seyedeh Hoda, Abbasi, Azam, Saberi, Zahra, Rafati, Sima, Taslimi, Yasaman, Mohammadi, Akram Miramin, Khamesipour, Ali
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904837/
https://ncbi.nlm.nih.gov/pubmed/31582344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.09.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars